The experimental use and Bolar-type exemptions to patent infringement
Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows
Practice notesThe experimental use and Bolar-type exemptions to patent infringement
Produced in partnership with Charlie French of Bristows and Milly Wickson of Bristows
Practice notespatent systems are intended to foster innovation, not to impede it. For this reason, the patent laws of many jurisdictions contain exemptions to infringement for experimental use of patented inventions.
This Practice Note examines the two principal research exemptions to patent infringement available under UK law, namely, the general experimental use exemption and the specific ‘Bolar-type’ exemption, including how they have developed in recent years and how they may continue to do so in the future. It also discusses the supplementary protection certificate (SPC) manufacturing waiver which provides an exception to infringement of SPCs (SPCs extend the patent protection for certain medicinal products).
Following Brexit, the body of EU-derived laws has been preserved and converted into UK domestic law with effect on IP completion day (11 pm on 31 December 2020). Relevant Assimilated EU law and Brexit SIs are discussed in the Bolar-type exemption and SPC manufacturing waiver sections below.
Assimilated law is the name given to retained EU law (‘REUL’) which remains
To view the latest version of this document and thousands of others like it,
sign-in with LexisNexis or register for a free trial.